Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M10.6Revenue (TTM) $M12.8Net Margin (%)-147.3Altman Z-Score-24.5
Enterprise Value $M-5.4EPS (TTM) $-7.6Operating Margin %-149.4Piotroski F-Score3
P/E(ttm)--Beneish M-Score23.2Pre-tax Margin (%)-147.3Higher ROA y-yY
Price/Book1.810-y EBITDA Growth Rate %--Quick Ratio2.5Cash flow > EarningsN
Price/Sales0.75-y EBITDA Growth Rate %--Current Ratio2.5Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-70.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-270.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M2.7ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ONTX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ONTXGeorge Soros 2014-09-30 Sold Out $43 - $56.4
($50.65)
$ 3.86-92%Sold Out0
ONTXGeorge Soros 2014-06-30 Buy $41.8 - $63.4
($52.59)
$ 3.86-93%New holding108
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ONTX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ONTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Michael & Jane Hoffman 2013 De10% Owner 2014-02-21Buy143$8470-99.95view
Hoffman Michael BDirector, 10% Owner 2014-02-21Buy143$8470-99.95view
Kumar RameshPresident and CEO 2014-02-10Sell34$15070-99.97view
Kumar RameshPresident and CEO 2014-02-03Sell60$15050-99.97view
Hoffman Michael BDirector, 10% Owner 2014-01-27Buy57$11920-99.97view
Michael & Jane Hoffman 2013 De10% Owner 2014-01-27Buy57$11920-99.97view
Michael & Jane Hoffman 2013 De10% Owner 2013-11-22Buy5$14390-99.97view
Hoffman Michael BDirector, 10% Owner 2013-11-22Buy5$14390-99.97view
Reddy E PremkumarDirector 2013-11-18Buy5$12100-99.97view
Hoffman Michael BDirector, 10% Owner 2013-11-18Buy5$11870-99.97view

Quarterly/Annual Reports about ONTX:

    News about ONTX:

    Articles On GuruFocus.com
    Weekly 3-Year Low Highlights: VCRA, CLUB, ARGS, ONTX, BOTA Jun 08 2014 

    More From Other Websites
    Onconova Announces Expiration of Oversubscribed Rights Offering Jul 27 2016
    Onconova Announces Expiration of Oversubscribed Rights Offering Jul 27 2016
    1:56 am Onconova Therapeutics adjusts the price and related pricing information for its previously... Jul 26 2016
    Onconova Adjusts Pricing of Rights Offering Jul 22 2016
    Onconova Adjusts Pricing of Rights Offering Jul 22 2016
    Onconova Announces Enrollment of First Patient in Japan by SymBio Jul 19 2016
    ONCONOVA THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Jul 13 2016
    Onconova Announces Commencement of Subscription Period for Previously Announced Rights Offering Jul 08 2016
    Onconova Announces Commencement of Subscription Period for Previously Announced Rights Offering Jul 08 2016
    Onconova Reminds Shareholders That Rights Offering Ownership Day is Friday, July 1, 2016 Jul 01 2016
    Onconova Reminds Shareholders That Rights Offering Ownership Day is Friday, July 1, 2016 Jul 01 2016
    Onconova Announces Price Range and Change of Key Dates for Rights Offering Jun 29 2016
    Onconova Announces Price Range and Change of Key Dates for Rights Offering Jun 29 2016
    Onconova Informs Stockholders of Key Dates Related to Announced Rights Offering Jun 20 2016
    Onconova Presents Clinical Data from Oral Rigosertib and Azacitidine Combination Study in... Jun 13 2016
    Onconova Presents Clinical Data from Oral Rigosertib and Azacitidine Combination Study in... Jun 13 2016
    6 Stocks Under $10 Making Big Moves Higher Jun 08 2016
    ETF’s with exposure to Onconova Therapeutics, Inc. : June 6, 2016 Jun 06 2016
    Onconova Announces Presentations Highlighting IV Rigosertib and Oral Rigosertib/Azacitidine... Jun 06 2016
    Onconova Announces Presentations Highlighting IV Rigosertib and Oral Rigosertib/Azacitidine... Jun 06 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)